# Elizabeth Plimack, MD, MS – FDA Inspection, Sep 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/elizabeth-plimack-md-ms/11afbabb-442a-4470-9f1e-0830f5d43fb2
Source feed: FDA_Inspections

> FDA inspection 1102867 of Elizabeth Plimack, MD, MS, September 26, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102867
- Company Name: Elizabeth Plimack, MD, MS
- Inspection Date: 2019-09-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anastasia-i-onuorah/d081d002-e4a4-4001-ba06-b71ff9fbf9f7)
- [Company Rep](https://www.keypedia.com/people/christopher-bastedo/e2e8432e-31a5-4f2b-af04-19f224f92b2e)
- [Company Rep](https://www.keypedia.com/people/stephanie-c-mangigian/0cf25e6b-1e5d-4088-a13c-11483e2380ba)

Company: https://www.keypedia.com/companies/elizabeth-plimack-md-ms/6d81948e-a35b-45b6-89c0-bdada6348fea

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c